Profile Core value Main business Legitimacy Social Responsibility
                          Patents Research Direction Technology Strength
                        API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
                        Production management QC Quality System branch factory




                        Products Center
                      Paclitaxel (Semi-synthetic)
                      Paclitaxel (Natural)
                      Docetaxel Anhydrous
                      Docetaxel Trihydrate
                      Irinotecan HCl Trihydrate 99.5%
                      Etoposide USP31
                      Palonosetron Hydrochloride
                        N-1 stage of Paclitaxel and Docetaxel
                        Main Intermediates
                      10-Deacetylbaccatin III
                      Baccatin III
                        Side chain for Paclixel semi-Synthetic
                      (4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
                        Side chain of Docetaxel
                      (4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
                        Side chain for Paclitaxel and Docetaxel
                      Ethyl (2R,3S)-3-Phenylisoserine Ester
                      Your location:Home>>About us>>Social Responsibility

                      Jinhe is fully aware that the development of enterprises is not only trying to obtain more economic benefits, but also trying to make more contribution to society, being an "enterprise citizen” beneficial to society.
                      Jinhe has always been conscientious of its production impact on environment, by actively controlling the emission of pollutants and heavily investing in the treatment of the pollutions. For many years, Jinhe has passed all inspection and assessment by State Environment Inspection Service.

                      Jinhe focuses on the conservation of resources. Based on our own research results, Jinhe made in-depth study on the comprehensive utilization of Taxus, turning waste into useful, and greatly improved the comprehensive utilization efficiency of endangered species “Taxus”.

                      Jinhe pays high attention on production cost control of anti-cancer drugs raw materials, and is committed to provide customers with low-cost raw materials of anticancer drug, thereby reducing the cost of anti-cancer drug products, so that more cancer patients can afford the expensive anticancer drug products, bringing more benefit to cancer patients.

                      CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
                      HOME About us Products R & D Production and QA Contact us CHINESE